These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Francisco V; Ruiz-Fernández C; Pino J; Mera A; González-Gay MA; Gómez R; Lago F; Mobasheri A; Gualillo O Biochem Pharmacol; 2019 Jul; 165():196-206. PubMed ID: 30910694 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy. Gonzalez-Gay MA; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Miranda-Filloy JA; Llorca J Ann N Y Acad Sci; 2010 Apr; 1193():153-9. PubMed ID: 20398022 [TBL] [Abstract][Full Text] [Related]
5. Changes in serum adipokines profile and insulin resistance in patients with rheumatoid arthritis treated with anti-TNF- Corrado A; Colia R; Rotondo C; Sanpaolo E; Cantatore FP Curr Med Res Opin; 2019 Dec; 35(12):2197-2205. PubMed ID: 31397188 [No Abstract] [Full Text] [Related]
6. Cell adhesion molecules and plasminogen activator inhibitor type-1 (PAI-1) in patients with rheumatoid arthritis: influence of metabolic syndrome. de Sá MC; Simão ANC; de Medeiros FA; Iriyoda TMV; Costa NT; Alfieri DF; Flauzino T; Sekiguchi BA; Lozovoy MAB; Reiche EMV; Maes M; Dichi I Clin Exp Med; 2018 Nov; 18(4):495-504. PubMed ID: 30008151 [TBL] [Abstract][Full Text] [Related]
7. Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration. Guin A; Sinhamahapatra P; Misra S; Choudhury Mazumder SR; Chatterjee S; Ghosh A Biomed J; 2019 Dec; 42(6):394-402. PubMed ID: 31948603 [TBL] [Abstract][Full Text] [Related]
8. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus? Danve AS; Kulkarni S Am J Ther; 2017 May; 24(3):e347-e350. PubMed ID: 26103543 [TBL] [Abstract][Full Text] [Related]
9. Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure? Kotyla PJ Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895751 [TBL] [Abstract][Full Text] [Related]
11. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Woolley DE; Tetlow LC Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391 [TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance and metabolic syndrome - a different image of disorders in rheumatoid arthritis and ankylosing spondylitis]. Dąbrowski P; Majdan M Wiad Lek; 2015; 68(3):235-41. PubMed ID: 26753206 [TBL] [Abstract][Full Text] [Related]
13. Obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients. Castillo-Hernandez J; Maldonado-Cervantes MI; Reyes JP; Patiño-Marin N; Maldonado-Cervantes E; Solorzano-Rodriguez C; de la Cruz Mendoza E; Alvarado-Sanchez B Rev Bras Reumatol Engl Ed; 2017; 57(4):320-329. PubMed ID: 28743359 [TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Gremese E; Ferraccioli G Autoimmun Rev; 2011 Aug; 10(10):582-9. PubMed ID: 21539940 [TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis, insulin resistance, and diabetes. Nicolau J; Lequerré T; Bacquet H; Vittecoq O Joint Bone Spine; 2017 Jul; 84(4):411-416. PubMed ID: 27777170 [TBL] [Abstract][Full Text] [Related]
16. Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis. Ormseth MJ; Lipson A; Alexopoulos N; Hartlage GR; Oeser AM; Bian A; Gebretsadik T; Shintani A; Raggi P; Stein CM Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1410-5. PubMed ID: 23592527 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320 [TBL] [Abstract][Full Text] [Related]
18. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Romas E; Gillespie MT; Martin TJ Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640 [TBL] [Abstract][Full Text] [Related]
19. Temporal expression patterns of distinct cytokines and M1/M2 macrophage polarization regulate rheumatoid arthritis progression. Kung CC; Dai SP; Chiang H; Huang HS; Sun WH Mol Biol Rep; 2020 May; 47(5):3423-3437. PubMed ID: 32277445 [TBL] [Abstract][Full Text] [Related]
20. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy. Gonzalez-Gay MA; Vazquez-Rodriguez TR; Garcia-Unzueta MT; Berja A; Miranda-Filloy JA; de Matias JM; Gonzalez-Juanatey C; Llorca J Clin Exp Rheumatol; 2010; 28(1):56-62. PubMed ID: 20346239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]